Flomics is developing novel blood-based diagnostic tools for a broad range of complex diseases. Our proprietary technology accurately identifies pattern changes in the circulating long RNA molecules of patients. With deep learning algorithms we identify RNA changes associated with disease states in a faster, cheaper and non-invasive way.
| Website | http://www.flomics.com |
| Revenue | $20 million |
| Employees | 22 (21 on RocketReach) |
| Founded | 2018 |
| Address | Carrer de Roc Boronat, 31, Barcelona, Catalonia 08005, ES |
| Technologies |
JavaScript
,
HTML
,
PHP
+23 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Genetics, Health Care, Health Diagnostics, Machine Learning, Artificial Intelligence, Data and Analytics, Software |
| Keywords | Blood Diagnostics, Rna Biomarkers, Deep Learning Diagnostics, Molecular Diagnostics, Novel Diagnostics, Biomarker Discovery, Liquid Biopsy, Disease Diagnostics, Early Disease Detection, Precision Medicine, Rna Sequencing, Personalized Medicine, Diagnostic Tools, Pattern Recognition, Diagnostic Technology, Blood Tests, Health Diagnostics |
| Competitors | Roche, Thermo Fisher Scientific, BD, Merck Group, Agilent Technologies, Illumina, PerkinElmer, Inc., QIAGEN, Genomatix AG, Bio-Rad Magyarország Kft. +55 more (view full list) |
Looking for a particular Flomics employee's phone or email?
The Flomics annual revenue was $20 million in 2026.
João Curado is the Co-Founder and CEO of Flomics.
21 people are employed at Flomics.
Flomics is based in Barcelona, Catalonia.